Close

Lilly To Participate In Morgan Stanley Global Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases

New global brand creates a stronger platform for innovation,...

Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development 

Centrix Pharma Solutions, a UK-based Contract Development Manufacturing Organisation...

Syntegon Expands Sepion Series With New Pilot-Scale Tablet Coater

Syntegon completes its coater portfolio with new Sepion...
- Advertisement -

Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015. Sue Mahony, Ph.D., senior vice president and president of Lilly Oncology and Richard Gaynor, M.D., senior vice president of product development and medical affairs for Lilly Oncology, will participate in a fireside chat at 3:30 p.m., Eastern Daylight Time.

A live audio webcast will be available on the “Webcasts & Presentations” section of Lilly’s investor website at http://investor.lilly.com/events.cfm. A replay of the fireside chat will be available for approximately 90 days.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases

New global brand creates a stronger platform for innovation,...

Centrix Pharma Solutions and University of Sussex partner to advance data-driven pharmaceutical development 

Centrix Pharma Solutions, a UK-based Contract Development Manufacturing Organisation...

Syntegon Expands Sepion Series With New Pilot-Scale Tablet Coater

Syntegon completes its coater portfolio with new Sepion...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »